Selective inhibition of histone deacetylase 6 alters the composition of circulating blood cells in a lethal septic model

Journal of Surgical Research

Volumn 190, Issue 2, 2014, Pages 647-654

  Zhao, Ting ^a   Li, Yongqing ^b   Liu, Baoling ^b   Halaweish, Ihab ^b   Mazitschek, Ralph ^a,c   Alam, Hasan B ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Blood; Granulocyte; Histone deacetylase 6; Lymphocyte; Sepsis; Tubastatin A

Indexed keywords

DIMETHYL SULFOXIDE; HEMOGLOBIN; HISTONE DEACETYLASE 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BLOOD CELL; CELL COMPOSITION; CIRCULATION; CONTROLLED STUDY; ENZYME INHIBITION; ERYTHROCYTE COUNT; EXPERIMENTAL LIGATION; GRANULOCYTE; HEMATOCRIT; HEMATOLOGY ANALYZER; LEUKOCYTE; LYMPHOCYTE COUNT; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

BLOOD; GRANULOCYTE; HISTONE DEACETYLASE 6; LYMPHOCYTE; SEPSIS; TUBASTATIN A;

ANIMALS; DISEASE MODELS, ANIMAL; HEMATOCRIT; HEMOGLOBINS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; INDOLES; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; PLATELET COUNT; RANDOM ALLOCATION; SEPSIS;

EID: 84904262333     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.01.056     Document Type: Article

References (50)

1. J.S. Boomer, K. To, and K.C. Chang et al. Immunosuppression in patients who die of sepsis and multiple organ failure JAMA 306 2011 2594
2. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303
3. D.C. Angus, and T. van der Poll Severe sepsis and septic shock N Engl J Med 369 2013 840
4. V.M. Ranieri, B.T. Thompson, and P.S. Barie et al. Drotrecogin alfa (activated) in adults with septic shock N Engl J Med 366 2012 2055
5. R.P. Wenzel, and M.B. Edmond Septic shock-evaluating another failed treatment N Engl J Med 366 2012 2122
6. M.R. Shakespear, M.A. Halili, K.M. Irvine, D.P. Fairlie, and M.J. Sweet Histone deacetylases as regulators of inflammation and immunity Trends in Immunology 32 2011 335
7. A. Valenzuela-Fernandez, J.R. Cabrero, J.M. Serrador, and F. Sanchez-Madrid HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions Trends in Cell Biology 18 2008 291
8. Y. Li, B. Liu, and H. Zhao et al. Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents Shock 32 2009 517
9. Y. Li, B. Liu, and E.Y. Fukudome et al. Surviving lethal septic shock without fluid resuscitation in a rodent model Surgery 148 2010 246
10. T. Zhao, Y. Li, and B. Liu et al. Novel pharmacologic treatment attenuates septic shock and improves long-term survival Surgery 154 2013 206
11. D. Rittirsch, M.S. Huber-Lang, M.A. Flierl, and P.A. Ward Immunodesign of experimental sepsis by cecal ligation and puncture Nat Protoc 4 2009 31
12. A.M. Mohr, I.O. ElHassan, and E.J. Hannoush et al. Does beta blockade postinjury prevent bone marrow suppression? J Trauma 70 2011 1043 discussion 9-50
13. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693
14. M. Haberland, R.L. Montgomery, and E.N. Olson The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat Rev Genet 10 2009 32
15. J. Fullgrabe, N. Hajji, and B. Joseph Cracking the death code: apoptosis-related histone modifications Cell Death Differ 17 2010 1238
16. Y. Zhang, B. Gilquin, S. Khochbin, and P. Matthias Two catalytic domains are required for protein deacetylation The J biol chem 281 2006 2401
17. H. Zou, Y. Wu, M. Navre, and B.C. Sang Characterization of the two catalytic domains in histone deacetylase 6 Biochem Biophysical Res Commun 341 2006 45
18. S.J. Haggarty, K.M. Koeller, J.C. Wong, C.M. Grozinger, and S.L. Schreiber Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation Proc Natl Acad Sci United States America 100 2003 4389
19. C. Hubbert, A. Guardiola, and R. Shao et al. HDAC6 is a microtubule-associated deacetylase Nature 417 2002 455
20. P. Bali, M. Pranpat, and J. Bradner et al. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors The J biol chem 280 2005 26729
21. J.J. Kovacs, P.J. Murphy, and S. Gaillard et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor Mol Cell 18 2005 601
22. M. Triantafilou, and K. Triantafilou Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide Biochem Soc Trans 32 2004 636
23. G.I. Aldana-Masangkay, and K.M. Sakamoto The role of HDAC6 in cancer J Biomed Biotechnol 2011 2011 875824
24. E.A. Eklund, and L.C. Platanias Inhibition of histone deacetylase 6 as a therapeutic strategy for acute lymphocytic leukemia Leuk Lymphoma 52 2011 1421
25. B. Hackanson, L. Rimmele, and M. Benkisser et al. HDAC6 as a target for antileukemic drugs in acute myeloid leukemia Leuk Res 36 2012 1055
26. L. Santo, T. Hideshima, and A.L. Kung et al. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma Blood 119 2012 2579
27. R. Schulz, N.D. Marchenko, and L. Holembowski et al. Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression J Exp Med 209 2012 275
28. D.D. Lemon, T.R. Horn, and M.A. Cavasin et al. Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension J Mol Cell Cardiol 51 2011 41
29. M.A. Rivieccio, C. Brochier, and D.E. Willis et al. HDAC6 is a target for protection and regeneration following injury in the nervous system Proc Natl Acad Sci U S A 106 2009 19599
30. K.V. Butler, J. Kalin, C. Brochier, G. Vistoli, B. Langley, and A.P. Kozikowski Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A J Am Chem Soc 132 2010 10842
31. D.M. Underhill, and A. Ozinsky Phagocytosis of microbes: complexity in action Annual Review of Immunology 20 2002 825
32. J.A. Hoffmann, F.C. Kafatos, C.A. Janeway, and R.A. Ezekowitz Phylogenetic perspectives in innate immunity Science 284 1999 1313
33. A. Mehta, R. Brewington, and M. Chatterji et al. Infection-induced modulation of m1 and m2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis Shock 22 2004 423
34. A. Ayala, and I.H. Chaudry Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis Shock 6 Suppl 1 1996 S27
35. C. Munoz, J. Carlet, C. Fitting, B. Misset, J.P. Bleriot, and J.M. Cavaillon Dysregulation of in vitro cytokine production by monocytes during sepsis The Journal of Clinical Investigation 88 1991 1747
36. X. Huang, F. Venet, and Y.L. Wang et al. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis Proc Natl Acad Sci United States America 106 2009 6303
37. L. Tserel, R. Kolde, and A. Rebane et al. Genome-wide promoter analysis of histone modifications in human monocyte-derived antigen presenting cells BMC Genomics 11 2010 642
38. S.S. Chen, A.J. Jenkins, and H. Majewski Elevated plasma prostaglandins and acetylated histone in monocytes in Type 1 diabetes patients Diabet Med 26 2009 182
39. H. Shimada, N. Takiguchi, and O. Kainuma et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer Gastric Cancer 13 2010 170
40. H. Cho, H.W. Hur, and S.W. Kim et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment Cancer Immunol Immunother 58 2009 15
41. R. Zahorec Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill Bratisl Lek Listy 102 2001 5
42. R.S. Hotchkiss, and D.W. Nicholson Apoptosis and caspases regulate death and inflammation in sepsis Nat Rev Immunol 6 2006 813
43. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138
44. R.S. Hotchkiss, P.E. Swanson, and B.D. Freeman et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction Crit Care Med 27 1999 1230
45. R.S. Hotchkiss, P.E. Swanson, J.P. Cobb, A. Jacobson, T.G. Buchman, and I.E. Karl Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice Crit Care Med 25 1997 1298
46. C. Oberholzer, A. Oberholzer, M. Clare-Salzler, and L.L. Moldawer Apoptosis in sepsis: a new target for therapeutic exploration FASEB J 15 2001 879
47. E.F. de Zoeten, L. Wang, and K. Butler et al. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells Mol Cell Biol 31 2011 2066
48. R. Zini, R. Norfo, and F. Ferrari et al. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression Exp Hematol 40 2012 1043
49. K. Yamamura, K. Ohishi, and N. Katayama et al. Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis Br J Haematol 135 2006 242
50. B. Liu, K. Ohishi, and K. Yamamura et al. A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis Exp Hematol 38 2010 685